PRKN and cancer: The data revealed that knockout of ATF4 significantly attenuated the mRNA and protein levels of Parkin in cancer cells under physiological and erastin or RSL3 or cystine deprivation treatment conditions (Figure 3E–G; Figure S3A–J, Supporting Information).